Skip to main content

by Tony Jones, CEO, One Nucleus

There are times when it can feel like a small world when chance meetings and connections are encountered. On the flip side, when a company is seeking the right investor, collaborator or client, then the world can seem awfully big without some guidance of where to look.   

Biotech and Pharma Investment Raised Between June 2020 and June 2025 

With the global deal count and investment raised remaining somewhat challenged, then perhaps the dealmaker’s world feels smaller but less connected. The UK, accounting for around approximately 7% of total investment raised and deal count reflecting the global trends, One Nucleus dedicates its efforts to maintaining strong collaborative relationships with those enabling global dealmaking, in order to support our members in securing those vital dollars, pounds and euros for growth, and to translate their innovative solutions towards impacting patient outcomes, whether directly or indirectly.

Set out below are some key opportunities to meet with potential investors, pharma dealmakers, and R&D partners through One Nucleus collaborations around bio-partnering and investor conferences in UK, US and Europe during the rest of 2025. The opportunities below range by event but include:

  • Discounted registration fees
  • Enhanced profiling opportunities
  • Pitching opportunities
  • 1-2-1 partnering.

September in Cambridge, UK

BioCentury Grand Rounds Conference

One Nucleus is delighted to be one of the Regional Host Committee RHC) working with BioCentury to bring their inaugural Grand Rounds - Europe conference to Cambridge this autumn.

  • 17-19 September
  • Attracting top VC’s, pharma BD&L and R&D leader teams
  • Keynotes, presentations and posters
  • 1-2-1 partnering
  • One Nucleus members receive 15% discount off registration fees.

Full details via https://onenucleus.com/civicrm/event/info?reset=1&id=1893

Regional Host Committee members: AstraZeneca, Babraham Research Campus, Cambridge University Health Partners, Cambridge Innovation Capital, Innovate Cambridge, o2h discovery and Wellcome Genome Campus. 

September in Boston, MA

  • 16-17 September 
  • Co-produced by LSX and EBD Group 
  • Leaders from the US biotech, medtech and pharmatech sectors
  • 1-2-1 partnering
  • One Nucleus members receive 15% discount off registration fees
  • https://onenucleus.com/lsx-world-congress-usa

     

  • 17 September in-person
  • 18-19 September online
  • Investor panels & company pitching
  • 1-2-1 partnering
  • One Nucleus members receive $200 discount off registration fees.
  • https://onenucleus.com/resi-boston-0

October in Gothenburg, Sweden

  • 13-14 October
  • Fastest growing life science event in the Nordic region
  • Produced by Sweden Bio
  • Nordic Start Pitch Competition
  • One Nucleus members receive 15% discount off registration
  • Full details via NLSDays.

November in Vienna, Austria

  • 1-3 November
  • Europe’s flagship partnering event
  • 5000+ attendees
  • Immersive conference agenda
  • Enhanced profiling opportunities available on the One Nucleus exhibition booth

December in London, UK

  • 3 December
  • 25th Edition of One Nucleus’s flagship London event
  • High content mix of keynotes, exhibition, partnering and networking
  • NEW for 2025 – Company Pitching stream
  • Delegate fees from £325 + VAT
  • Genesis Fringe events 1-2 December
  • Combi-Ticket with RESI London available
  • https://www.genesisconference.com/

     

  • 4 December in-person
  • 8-9 December online
  • Investment focussed pitching and partnering
  • Combi-Ticket with Genesis 2025 available
  • Full details at RESI London 2025. 

Helping to Join the Dots

Much like the life science ecosystem itself, collaboration is at the heart of One Nucleus as we aim to create opportunities for our community to knit together their success journey, including in this context the need to meet the right partners. The above events are all well-established events, albeit RESI London is relatively new to the parade, but RESI has a long history elsewhere.

Whilst providing discounts and profiling mechanisms, One Nucleus is increasingly armed with data and connections to help members target their partnering outreach, having now subscribed to providers such as Biotechgate and PitchBook. Access to these industry data complements the extensive One Nucleus connectivity to enable our members to get the latest insights and contacts appropriate to their deal-making strategy.

Getting in Touch

If you require any further information on accessing any of the above discounts and profiling opportunities, or would simply like to meet with members of the One Nucleus team to discuss how we can help you achieve your partnering goals, do contact the team at [email protected].